Advanced Oncotherapy is a specialist developer and provider of the next generation of particle therapy systems that makes radiation less toxic for patients. Our aim is to create a bright future in cancer care with our advanced LIGHT technology. Vision: To develop a more affordable proton-based radiotherapy system, using an innovative and clinically more effective technology, and saving more cancer lives. Mission: To facilitate the wider use of radiation with protons for treating all forms of radio-sensitive cancers by commercialising a novel technology, and building on the success and scientific know-how of CERN (Centre Européen pour la Recherche Nucléaire).
TypePublic
HQLondon, GB
Founded1994
Size (employees)51 (est)
Websiteadvancedoncotherapy.com
Advanced Oncotherapy was founded in 1994 and is headquartered in London, GB
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Advanced Oncotherapy Office Locations

Advanced Oncotherapy has offices in London, Syracuse and Rolle
London, GB (HQ)
4-7 Manchester St
Rolle, CH
23 Route de Genève
Syracuse, US
1009 E Fayette St
Show all (3)
Report incorrect company information

Advanced Oncotherapy Financials and Metrics

Advanced Oncotherapy Revenue

Advanced Oncotherapy's revenue was reported to be £84.24 k in FY, 2015 which is a 20.8% decrease from the previous period.
GBP

Net income (FY, 2017)

(13.7 m)

EBITDA (FY, 2017)

(14.1 m)

EBIT (FY, 2017)

(14.5 m)

Cash (31-Dec-2017)

56.5 k
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.7 m1.8 m2.1 m2.9 m3.4 m1.4 m71 k100 k68.9 k106.4 k84.2 k

Revenue growth, %

54%(21%)

Cost of goods sold

73 k84 k163 k416 k455.3 k1.2 m713 156 k202.7 k

Gross profit

1.7 m1.7 m2 m2.4 m3 m200 k99.3 k(87 k)(96.3 k)
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

7 m2.3 m119 k2.5 m268.6 k148.4 k24.2 k57.8 k148.8 k1.5 m9 m1.4 m56.5 k

Accounts Receivable

339 k360 k152 k128.6 k173.4 k2.1 m1.1 m2.9 k28.6 k73.6 k

Inventories

1 k37.2 k1.1 m4.4 m7.4 m7.6 m

Current Assets

7.3 m4.6 m665 k3 m781.1 k2.7 m1.5 m1.5 m1.4 m3.2 m16.7 m12.5 m12.5 m
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(383 k)678 k1.5 m(1.7 m)(1.8 m)(3.4 m)(2.3 m)(1.9 m)(3.4 m)(5.7 m)(5.8 m)(10.4 m)(13.7 m)

Cash From Operating Activities

1.7 m1.4 m(625.5 k)(742.1 k)(4.3 m)(774.2 k)(1.4 m)(2.9 m)(6.6 m)(9.8 m)(10.9 m)(9.6 m)

Cash From Financing Activities

3.4 m5.6 m13.9 m4.9 m(19.5 m)(23.4 m)2.4 m2.5 m9.2 m21.1 m13.1 m16.8 m

Net Change in Cash

4.6 m4.2 m4.3 m(2.2 m)(507.3 k)(90.4 k)386.8 k91.2 k1.3 m7.5 m(7.5 m)(1.4 m)
GBPY, 2017

Financial Leverage

1.6 x
Show all financial metrics
Report incorrect company information

Advanced Oncotherapy Online and Social Media Presence

Embed Graph
Report incorrect company information

Advanced Oncotherapy Company Life and Culture

Report incorrect company information